RF INTRALUMINAL ABLATION DEVICE
BACKGROUND OF THE INVENTION
This invention relates to tissue ablation devices and the method of using such
devices and particularly to the treatment of benign prostatic hyperplasia (BPH).
BPH, the nonmalignant enlargement of the prostate gland, is quite common in
men as they grow older and frequently causes the constriction of the patient's
urethral canal, interfering with the flow of urine therethrough. Treatment modalities
for the BPH condition has varied over the years. For many years constricted
urethral passagewaya caused by BPH were dilated by passing a series of bogies
with increasingly larger distal tips through the constricted passageway. More
recently, a similar method has been proposed whereby a dilatation balloon on the
distal end of a catheter is expanded within the stenotic region of the urethral canal to
expand the passageway. This expansion of the stenotic urethral canal can be
effective, but the benefits are frequently short-lived, in that the constriction returns a
short while, e.g. a year or two, after the initial dilatation.
One of the more frequently used modalities is a surgical transurethral
resection of the prostate (TURP) which involves insertion of a resectoscope through
the urethra and removing the constricting tissue by means of a hot wire. However,
this procedures can result in incontinence, impotence and a variety of other
problems. Moreover, this procedure usually require general anaesthesia and a
significant hospital stay, all of which result in significant costs.
Another treatment modality of more recent origin involves debulking the
prostate gland by laser, RF, microwave energy, ultrasonic vibrations and the like
which is delivered into the gland by means of an elongated energy transmitting
member inserted into the prostatic tissue to be ablated. For example, PCT
application WO 92/10142 (Makower) describes the utilization of a catheter which is
advanced into the patient's urethral canal until its distal end is situated within the
prostatic urethra and an elongated needle is curved out of the distal end of the
catheter into an adjacent lobe of the patient's prostate gland. An optical fiber is
advanced through the inner lumen of the needle into the prostate gland and laser
energy is emitted from the distal end of the optical fiber to ablate prostatic tissue. A
pair of elongated needles can be used, one needle which is curved into one lobe of
the prostate gland and the other needle curved into the opposite lobe.
Similar treatments and ablation devices for such treatments can be found in
U.S. Patent No. 4,565, 200 (Cosman), U.S. Patent No. 5.385,544 (Edwards et al),
U.S. Patent No. 5,409,453 (Lundquist), U.S. Patent No. 5,435,805 (Edwards et al),
and U.S. Patent No. 5,470,309 (Edwards et al.) where the elongated energy
transmitting member is a metallic member with an exposed portion on the distal tip
thereof which acts as an emitting electrode. High frequency electrical energy is
passed through the energy transmitting member and emitted from the exposed
portion of the energy transmitting member, which acts as an emitting electrode, to
ablate the surrounding prostatic tissue and thereby debulk the patient's prostate
gland. See also U.S. Patent No. 4,950,267 (Ishihara et al.) which discloses a laser
based device for similar functions. The above patents are hereby incorporated by
reference in their entireties.
While there has been much development work in this field, the TUR technique
despite its shortcomings remains the conventional practice. What has been needed
is a system which does not require general anesthesia and which would facilitate
debulking BPH treatments which do not require extended hospital stays. The
present invention satisfies these and other needs.
SUMMARY OF THE INVENTION This invention is directed to an elongated tissue ablation device which has an
elongated shaft with an inner lumen extending therein and a handle on the proximal
end of the shaft with an interior chamber. An energy transmitting cartridge assembly
comprising an elongated energy transmitting member which has an insulating jacket
disposed about the member for a substantial length thereof and which is configured
along with its jacket to be slidably disposed within the inner lumen of the elongated
shaft of the ablation device and a cartridge housing secured to the proximal ends of
the energy transmitting member and the jacket thereof which is configured to be
slidably disposed within the inner chamber of the handle of the ablation device and
over the energy transmitting member. The energy transmitting cartridge housing is
provided with means to fix the relative longitudinal displacement between the energy
transmitting member and the insulating jacket so as to set the length of the distal
extremity of the energy transmitting member which extends out of the insulating
jacket, preferably before the energy transmitting member is advanced into adjacent
tissue for ablation. By being able to adjust the length of the energy transmitting
member which extends out of the insulating jacket, the same energy transmitting
member, and thus cartridge assembly can be used for a variety of prostate sizes.
There is no need for separate cartridge assemblies for different sized prostate
glands. Moreover, the cartridge assembly is replaceable to allow for the subsequent
reuse of the shaft and handle of the ablation device.
Preferably, the cartridge housing is provided with a projection configured to
extend through a slot or opening in a wall of the handle to allow for the manual
longitudinal movement of the cartridge assembly by this projection within the
ablation device to extend the distal end of the energy transmitting member out the
distal end of the elongated sheath and into adjacent tissue such as the patient's
prostatic urethral wall and prostate gland.
In accordance with one embodiment of the invention, means are provided to
advance the energy transmitting cartridge housing within the interior chamber of the
ablation device handle beyond the operating position thereof so that the energy
transmitting member attached thereto is advanced further into a mass of tissue to be
ablated than contemplated for the ablation procedure and then withdrawn back to its
operating position. This withdrawal pulls the energy transmitting member and its
insulating jacket to minimize the tenting of the tissue through which the energy
transmitting member initially penetrates, e.g. the prostatic urethral wall. Once in
place, suitable energy, such as high frequency (RF) electrical energy, laser energy,
ultrasonic energy and the like, is passed through the elongated energy transmitting
member and is emitted from the exposed distal extremity thereof to ablate the tissue
surrounding the distal extremity.
Because the energy transmitting assembly is a completely separate unit, it
may be withdrawn after use and discarded while the shaft and handle of the ablation
device may be cleaned up, sterilized and used again. Another advantageous
feature of the invention is the capability of adjusting the length of the energy
transmitting member either before inserting the ablation device into the patient or
after the device is inserted to handle a variety of prostate sizes. These and other
advantages will become more apparent from the following detailed description of the
invention when taken in conjunction with the accompanying exemplary drawings.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is an elevational view of an elongated ablation device which embodies
features of the invention.
Fig. 2 is an enlarged elevational view of the distal extremity of the ablation
device shown in Fig. 1.
Fig. 3 is an end view of the distal extremity shown in Fig. 2.
Fig. 4 is a transverse cross-sectional view of the distal extremity of the
ablation device shown in Fig. 2 taken along the lines 4-4.
Fig. 5 is a longitudinal cross-sectional view of the ablation device shown in
Fig. 1.
Fig. 6 is a longitudinal cross-sectional view of the ablation device shown in
Fig. 5 taken along the lines 6-6.
Fig. 7 is a transverse cross-sectional view of the ablation device shown in Fig.
6 taken along the lines 7-7.
Fig. 8 is an exploded perspective view of the handle of the ablation device
shown in Fig. 1.
Fig. 9 is a plan view, partially in section, of the cartridge assembly shown in
Fig. 8.
Fig. 10 is a longitudinal cross-sectional view of the cartridge assembly shown
in Fig. 9 taken along the lines 10-10.
Fig. 11 is an exploded perspective view of the cartridge assembly shown in
Figs. 9 and 10.
Fig. 12 is a partial elevational view, partially in section, of an alternative
embodiment which includes means to ensure energy delivery of electrical energy
only in a single operable location.
Fig. 13 is a rear view, partially in section, of the embodiment shown in Fig. 12.
Fig. 14 is a top view of the PC board shown in Figs. 12 and 13 schematically
showing the arrangement of electrical posts and electrical conductors which facilitate
the transmission of electrical energy at the operable location.
Fig. 15 is an elevational view of another embodiment wherein the electrodes
have a looped proximal ends which engage electrical contact points on the PC
board.
Fig. 16 is a top view, partially in section, of the embodiment shown in Fig. 15.
DETAILED DESCRIPTION OF THE INVENTION Reference is made to Figs. 1-5 which illustrate an ablation device 10
embodying features of the invention which generally includes a handle or adapter 11
having an interior chamber 12, an elongated shaft 13 and a pair of conduits 14
within the elongated shaft configured to receive elongated electrodes 15 and 16
having insulating jackets 17 and 18. The electrodes 15 and 16 are part of an
electrode cartridge 19 assembly which includes a cartridge housing 20. The
cartridge housing 20 receives and secures the proximal ends of the electrodes 15
and 16 and the jackets 17 and 18 and is slidably disposed within the interior
chamber 12 of the handle or adapter 11.
Each of the opposing walls 21 and 22 of the handle 11 are provided with
recesses 23 and 24 which controls the movement of the cartridge housing 20 within
the interior chamber 12. The locating pins 25 and 26 on the exterior of the cartridge
housing 20 ride along the ledges 27 and 28 defined by the recesses. Position A, as
shown in Figs. 5 and 11 , is the maximum thrust position for the cartridge housing,
position B is the operating position and position C is a nonoperating at-rest position.
While not shown in the drawings, a biasing means (e.g. a helical spring) may be
provided within the distal end of the interior chamber 12 to urge the return of
cartridge housing 20 from position A to position B as shown in Fig. 5.
The distal end or nose piece 28 of the elongated shaft 13 is rounded or blunt
to minimize trauma to the patient's urethra upon advancing the elongated shaft to
the desired location adjacent to the patient's prostate gland. The distal ends of the
electrode conduits 14 within the nose section 28 are curved so as to direct the distal
ends of the electrodes 15 and 16 and the insulating jackets 17 and 18 thereof
through the adjacent urethral wall into the patient's prostate gland. As shown in
Figs. 2 and 3, the distance the electrodes 15 and 16 extend out of the jackets 17
and 18 can be adjusted to provide a desired exposed electrode area to
accommodate a wide range of prostate gland sizes. The mechanism for adjustment
of the electrode exposure beyond the distal end of the insulation jacket 16 will be discussed hereinafter.
The electrode conduits 14 are defined by tubular guide members 29 which
extend to the stop member 30 within the interior chamber 12 of the handle 11. The
elongated shaft 13 of the ablation device 10 also has a central passageway 31
defined by tubular member 32 for an optical fiber 33 which has an angled face 34 for
lateral viewing of the stenotic region of the prostatic urethra to facilitate the desired
positioning of the electrodes within the patient's prostate gland. An eyepiece 35,
including lens elements (not shown), optically connected to the optical fiber 31 , is
provided on handle 11 to allow the physician or other operator to view the treatment
site. The elongated shaft 12 is also provided with a channel 36 defined by tubular
member 37 which allows for the delivery and aspiration of suitable fluids such a
saline to and from the treatment site.
The cartridge housing 20 is provided with projection or tab 38 on its upper
wall portion which extends out the slot 39 in the upper wall 40 of the handle 11 to
allow for the manual movement of the cartridge housing within the interior chamber
12 and, as a result, the longitudinal movement of the electrodes 15 and 16 and the
jackets 17 and 18 within the electrode conduits 14.
The relative longitudinal positions between the electrodes 15 and 16 and the
insulating jackets 17 and 18 may be adjusted by moving the tabs 41 and 42 which
extend out of the slots or openings 43 and 44 in the upper wall of the cartridge
housing 20. The electrodes 15 and 16 are secured by their proximal ends within the
legs 45 and 46 of slider member 47 as shown in Figs. 10 and 11 by a metallic collars
48 (only one shown in the drawings) which also facilitates electrical contact with the
PC board 49 secured with the interior of the slider member 47. The proximal ends of
the insulating jackets 17 and 18 are secured within the distal end of the slider
member 47 by means of a bearing or sealing collars 50 and 51 each of which has a
central passageway for the electrode 15 and 16 as shown in Fig. 10. Each of the
slots or openings 43 and 44 are provided with a plurality of recesses 52 and 53
which are configured to receive the protrusions 54 and 55 at the base of the tabs 41
and 42. The most distal recess provides the maximum electrode exposure, whereas
the most proximal recess provides the least exposure.
Also shown in Figs. 9 and 10 are electrical conductors 56 and 57 which
extend out the distal ends of the insulating jackets 17 and 18. These conductors are
connected by their distal ends to thermocouples (not shown) disposed in the distal
ends of the jackets, and are electrically connected by their proximal ends to the PC
board 49. The proximal extremity of the PC board 49 extends out proximal end of
the cartridge housing 20 and is suitably connected to a signal processor for
temperature sensing and to a high frequency power source by conventional means
not shown.
The dimensions of the ablation device 10 are selected to fit the particular
procedure which the device is to perform and the patient on which the procedure is
to be performed. The handle 11 is sized and preferably shaped to comfortably fit
within the hand of the operator. The handle, cartridge housing and other
components may be formed of suitable polymer materials such as polyethylene,
polypropylene, polyvinyl chloride, polycarbonate and the like. The spring 60, shown
in Fig. 8 and further described below with respect to ensuring electrode actuation
only at the proper location of the electrodes is operation, which urges the cartridge
housing 20 upwardly toward the top of the inner chamber 12 of the handle 11 is
preferably made from metallic materials such as stainless steel and the like. Other
conventional materials may also be utilized.
Reference is made to Figs. 12-14 which describe a system for ensuring that
the laser can be fired only when the electrodes are at a desirable location. As
shown, the springs 60 and 61 , which urge the cartridge housing 20 toward the upper
wall 40 to contact electrical contact posts 62 and 63 and 64 and 65 which protrude
slightly from the lower surface of the PC board 49. The RF electrical power, as
shown in Fig. 13, is delivered through electrical conductor 66 and 67 to posts 62 and
64 and the power is delivered from posts 63 and 65 to electrical conductors 68 and
69 to the electrodes 15 and 16 respectively. As shown in Fig. 14, RF power is
deliverable to the electrodes 15 and 16 only when the springs 60 and 61 electrically
interconnect the electrical posts 62 and 63 and 64 and 65. This ensures that the RF
energy burst will be delivered to the electrodes only when the electrodes are in the
correct position.
In Figs. 15 and 16 an embodiment is shown which ensures the positioning of
the electrodes 15 and 16 within the assembly so that the distal extremity of the
electrodes can be preshaped and the orientation of the preshaped distal extremity of
the electrodes can be controlled. The proximal ends of the electrodes 15 and 16 are
formed into loops 70 and 71 so that the lower portion of each of the loops contact
the electrical contacts 72 and 73 on the PC board. The upper portion of the loops
presses against the upper portion of the cartridge housing 20 to ensure pressured
contact with the electrical contacts on the PC board. The electrodes are provided
with positioning collars 74 and 75 crimped thereon which are configured to fit into the
series of recesses 76 and 77 provided to control the length of the distal portion of
the electrodes 17 and 18 which extend into the patient's prostate. In this
embodiment shown, the electrodes are fixed within the insulation and several
electrodes are usually provided with different lengths of exposed electrodes for
various sized prostates.
While the invention has been described herein primarily in terms of certain
preferred embodiments, various modifications and improvement can be made to the
invention. For example, the electrode may be replaced with an optical fiber system
which is optically connected to a source of laser energy. Other changes include
replacing the electrode with an elongated metallic style which is suitable for
transmitting ultrasonic vibrations. A variety of other modifications may be made
without departing from the scope of the invention. Moreover, although individual
features of one embodiment of the invention may be discussed herein or shown in
the drawings of the one embodiment and not in other embodiments, it should be
apparent that individual features of one embodiment may be combined with features
another embodiment or some or all of the embodiments.